SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Cepheid (CPHD) today announced that the World Health Organization (WHO) has assessed and listed Xpert® Ebola as eligible for procurement to Ebola affected countries. The program details can be found at: http://www.who.int/medicines/ebola-treatment/...proval/en/. Xpert Ebola is a molecular diagnostic test for Ebola Zaire Virus that delivers results in less than two hours. The test runs on the Cepheid GeneXpert® Systems, the world's leading molecular diagnostic platform with over 8,000 systems deployed globally in both developed and emerging market countries.

Actually, it did not take a great deal of time for this outfit to come up with an Ebola assay, get FDA emergency use authorization and now the above with WHO